NICE backs Qarziba for children with high-risk neuroblastoma

12th July 2018 Uncategorised 0

NHS funding for EUSA’s Pharma’s Qarziba has been approved to treat children with high-risk neuroblastoma.

More: NICE backs Qarziba for children with high-risk neuroblastoma
Source: News